Nalaganje...

Augmentation of VAMP-catalytic activity of botulinum neurotoxin serotype B does not result in increased potency in physiological systems

Botulinum neurotoxins (BoNTs) are used extensively as therapeutic agents. Serotypes A and B are available as marketed products. Higher doses of BoNT/B are required to reach an efficacy similar to that of products containing BoNT/A. Advances in our understanding of BoNT/B mechanism of action have aff...

Popoln opis

Shranjeno v:

Bibliografske podrobnosti
izdano v:	PLoS One
Main Authors:	Elliott, Mark, Maignel, Jacquie, Liu, Sai Man, Favre-Guilmard, Christine, Mir, Imran, Farrow, Paul, Hornby, Fraser, Marlin, Sandra, Palan, Shilpa, Beard, Matthew, Krupp, Johannes
Format:	Artigo
Jezik:	Inglês
Izdano:	Public Library of Science 2017
Teme:	Research Article
Online dostop:	https://ncbi.nlm.nih.gov/pmc/articles/PMC5628846/ https://ncbi.nlm.nih.gov/pubmed/28982136 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0185628
Oznake:	Označite Brez oznak, prvi označite!

Augmentation of VAMP-catalytic activity of botulinum neurotoxin serotype B does not result in increased potency in physiological systems

Podobne knjige/članki